Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantation
Authors:
Open Access
- 18 July 2005
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 36 (6) , 517-523
Abstract
Thrombotic microangiopathy (TMA) is a significant complication after hematopoietic stem-cell transplantation (HSCT); however, there is little information on it following reduced-intensity cord blood transplantation (RI-CBT). We reviewed the medical records of 123 adult patients who received RI-CBT at Toranomon Hospital between January 2002 and August 2004. TMA was diagnosed in seven patients based on intestinal biopsy (n=6) or autopsy results (n=1). While these patients showed some clinical symptoms such as diarrhea and/or abdominal pain, mental status alterations or neurological disorders were not observed in any of them. Laboratory results were mostly normal at the onset of TMA; >2% fragmented erythrocytes (n=1), 200 IU/dl lactic dehydrogenase (LD) (n=4). On endoscopic examination, TMA lesions, consisting of ulcers, erosions, and diffuse exfoliation, were distributed spottily from terminal ileum to rectum. Intestinal graft-versus-host disease (GVHD) and cytomegalovirus (CMV) colitis were confirmed in five and four patients, respectively. With therapeutic measures including supportive care (n=4), fresh frozen plasma (n=1), and a reduction of immunosuppressive agents (n=1), TMA improved in four patients. The present study demonstrates that intestinal TMA is a significant complication after RI-CBT. Since conventional diagnostic criteria can overlook TMA, its diagnosis requires careful examination of the gastrointestinal tract using endoscopy with biopsy.Keywords
This publication has 19 references indexed in Scilit:
- Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reducedTransplantation and Cellular Therapy, 2004
- Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host diseaseBone Marrow Transplantation, 2004
- Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioningBlood, 2003
- Transplantation-associated thrombotic microangiopathy: twenty-two years laterBone Marrow Transplantation, 2002
- Thrombotic Thrombocytopenic Purpura Following Stem Cell TransplantationLeukemia & Lymphoma, 2002
- Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemiaBone Marrow Transplantation, 1999
- FK506-ASSOCIATED THROMBOTIC MICROANGIOPATHYTransplantation, 1999
- von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic SyndromeNew England Journal of Medicine, 1998
- Red cell fragmentation (schistocytosis) after bone marrow transplantationBone Marrow Transplantation, 1998
- Endothelial cell activationKidney International, 1998